Garde Capital, Inc. Cyto Dyn Inc. Transaction History
Garde Capital, Inc.
- $1.52 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding CYDY
# of Institutions
9Shares Held
263KCall Options Held
0Put Options Held
0-
Mai Capital Management47.5KShares$10,4460.0% of portfolio
-
Diversified Trust CO45.8KShares$10,0730.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY45KShares$9,9000.0% of portfolio
-
Rfp Financial Group LLC Atlanta, GA41.5KShares$9,1190.0% of portfolio
-
Next Capital Management LLC32.5KShares$7,1500.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $179M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...